UK and Russia sign MoU on regulatory co-operation on medicines

29 Jan 2019

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health.

The Medicines and Healthcare products Regulatory Agency (MHRA) has signed a Memorandum of Understanding (MoU) with its Russian counterpart; the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the Russian Federation.

UK and Russia sign MoU on regulatory co-operation on medicines

This agreement will increase collaboration between the two bodies and further enhance co-operation in the field of regulation of medicines.

The MoU is designed to establish mechanisms of cooperation which will facilitate:

  • the exchange of information on medicines regulations
  • the exchange of safety information
  • co-operation on Good Manufacturing Practice (GMP) inspections
  • collaboration on enforcement activities.
  • Dr Sam Atkinson, MHRA’s Director of the Inspection, Enforcement and Standards Division, said: "Working in an increasingly global environment, the sharing of intelligence between medicines regulators is the cornerstone of protecting the health system worldwide.

    "Formalising our already close working relationships with international counterparts helps facilitate this exchange of information.

    "This makes it easier for us to track down criminals, promote good practices internationally, and identify emerging safety trends to protect public health."

    Read More

    Related news

    HALIX starts operational production with new cGMP facility in Q4-2019

    HALIX starts operational production with new cGMP facility in Q4-2019

    15 Aug 2019

    The five-level production facility contains a state-of-the-art manufacturing line for viral vaccines and viral vectors and a separate protein manufacturing area with a capacity up to 1,000-L single-use bioreactors.

    Read more 
    Delivering complete aseptic vial handling solutions

    Delivering complete aseptic vial handling solutions

    14 Aug 2019

    Bringing freeze drying and vial washing/sterilizing technologies together with advanced and comprehensive vial and syringe filling capabilities.

    Read more 
    Hikma expands nasal spray capabilities

    Hikma expands nasal spray capabilities

    12 Aug 2019

    Company acquires unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products.

    Read more 
    How real-world data can revolutionise drug development

    How real-world data can revolutionise drug development

    9 Aug 2019

    Utilising the current data environment and its data pools for the benefit of advancing research.

    Read more 
    Sartorius launches new services for mammalian cell bank manufacturing

    Sartorius launches new services for mammalian cell bank manufacturing

    8 Aug 2019

    Integrated package of new and established services saves time and minimizes risks.

    Read more 
    Using mobile phones to fight Alzheimer’s disease

    Using mobile phones to fight Alzheimer’s disease

    8 Aug 2019

    Researchers study how radiofrequency electromagnetic fields could be used in Alzheimer’s disease therapy.

    Read more 
    Cambrex to be acquired by the Permira funds

    Cambrex to be acquired by the Permira funds

    7 Aug 2019

    The CDMO's shareholders will receive $60.00 per share in cash.

    Read more 
    Automation-compatible prepared culture media plate technology

    Automation-compatible prepared culture media plate technology

    6 Aug 2019

    Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.

    Read more 
    Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

    Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

    6 Aug 2019

    The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events.

    Read more 
    Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

    Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

    5 Aug 2019

    Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.

    Read more